血管アクセスデバイス市場：タイプ、年齢層、エンドユーザー、用途別-2025～2030年世界予測

血管アクセスデバイス市場は、2024年には51億1,000万米ドルとなり、2025年には54億8,000万米ドル、CAGR7.71％で成長し、2030年には79億8,000万米ドルに達すると予測されています。

今日のダイナミックな医療環境において、血管アクセスデバイス市場は、効率的なケアを提供するための重要な要素としてますます認識されるようになっています。中心静脈カテーテルや末梢血管アクセスデバイスなどの血管アクセスデバイスの使用拡大により、堅牢で信頼性が高く、適応性の高い医療ソリューションの必要性が浮き彫りになっています。これらの器具は、さまざまな治療や診断アプリケーションにおいて極めて重要であり、病院から在宅医療に至るまで、患者が効果的かつ安全に治療を受けられるようにします。

医療組織は、患者の転帰を改善するだけでなく、臨床プロセスを合理化するイノベーションを絶えず求めています。手技が進化するにつれて、これらの機器の技術的な高度化も進んでいます。新材料、先進的なカテーテル設計、生体適合性の向上などの統合により、メーカーは安全性と性能という2つの要求を満たすことができるようになりました。市場リーダーは研究開発への強いコミットメントを示し、価値観による医療を目指す産業全体の動向を反映しています。

市場の進化は、低侵襲治療への世界のシフトと外来治療への嗜好の高まりによってさらに形作られています。この変革は、ウェアラブル技術や遠隔モニタリングの開発によって支えられており、患者管理の枠組みに弾力性と適応性の新たなレイヤーを追加しています。全体として、現在の情勢は、イノベーション、戦略的コラボレーション、卓越した患者ケアに向けた絶え間ない推進力によって特徴付けられています。

血管アクセスデバイスの展望を再定義する変革的変化

近年の血管アクセスデバイス市場は、急速な技術進歩と進化する患者ケアのパラダイムに牽引され、変革的な変化を遂げています。新製品の革新は、機能性と患者の安全性の両方を重視した画期的なデザインの改善をもたらしました。コスト効率とともに性能指標が進歩するにつれ、製造業者は従来のモデルから、統合モニタリングとリアルタイムデータ分析を組み込んだ設計へと移行しつつあります。

医療プロバイダは、手技の正確性を高め、合併症発生率を低減し、患者の転帰改善に貢献する機器の採用を増やしています。こうしたシフトは単に製品属性に限った話ではなく、サプライチェーンの合理化、病院システムのデジタル統合、個別ケアの重視など、より広範なシステム変革の反映です。市場が拡大するにつれ、エビデンスによる実践が採用され、技術革新のペースが速まりました。さらに、規制プラクティスにおける新たな動向は、産業内の継続的な品質改善の文化を促し、標準化と安全プロトコルの強化を促進しました。

メーカーと利害関係者は現在、材料科学、流体力学、リアルタイムモニタリングの進歩を活用し、多様な臨床シナリオにおいてすべての機器が最適に機能するようにしています。このような進化により、市場は技術面での競合だけでなく、刻々と変化する患者層や医療提供モデルに対応する強靭性も備えています。

詳細な市場セグメンテーションによる洞察

市場セグメンテーション洞察は、血管アクセス装置産業の力学を支える複雑な側面を明らかにします。タイプによる分析では、中心静脈カテーテルと末梢血管アクセスデバイスの徹底的な調査が行われ、さらに末梢静脈カテーテル（長）と末梢静脈カテーテル（短）の精査が行われました。この微妙な分類は、各タイプに特有の機器使用パターンや技術進歩の動向を特定するのに役立ちます。年齢層によるセグメンテーションでは、成人、高齢者、小児を対象としており、ライフスパンにわたる患者固有のニーズと課題を包括的に見ることができます。

さらに、エンドユーザー別セグメンテーションでは、外来手術センター、在宅医療環境、病院やクリニックなどのセッティングに重点を置いており、これらのセッティングに固有のさまざまな臨床要件や手順基準が強調されています。分析の枠組みは、輸血、診断と検査、薬剤投与などの用途に拡大されています。薬剤管理では、抗生物質の点滴と化学療法に焦点を当てることで、特殊な治療プロトコールにおける市場需要の理解を深めています。この統合的なセグメンテーションアプローチにより、利害関係者は多様なセグメントのニーズに的確に合致した戦略を立てることが可能となり、製品やサービスが広範かつ複雑化する顧客層の期待に確実に応えることができるようになります。

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 慢性疾患の増加により、長期的な血管アクセスソリューションの継続的なニーズが生じています。
    • 輸液投与のための血管アクセスデバイスを必要とする外科手術の増加
  • 抑制要因
    • 高額な費用と償還問題、大規模な製品リコール
  • 機会
    • デバイス関連感染を減らすための革新的な抗菌コーティング技術の開発
    • 在宅医療セグメントの拡大により、ポータブルで使いやすい血管機器の需要が高まっている
  • 課題
    • VADに伴う合併症や感染症のリスクと規制上のハードル
• 市場セグメンテーション分析
  • タイプ：短期治療における末梢血管アクセスデバイスの採用増加
  • エンドユーザー：入院患者と外来患者の処置件数の増加により、病院やクリニックでの血管アクセスデバイスの利用が拡大
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治
  • 経済
  • 社会
  • 技術
  • 法律
  • 環境

第6章 血管アクセスデバイス市場：タイプ別

• イントロダクション
• 中心静脈カテーテル
• 末梢血管アクセスデバイス
  • 長末梢静脈カテーテル
  • 短末梢静脈カテーテル

第7章 血管アクセスデバイス市場：年齢層別

• イントロダクション
• 成人
• 高齢者
• 小児

第8章 血管アクセスデバイス市場：エンドユーザー別

• イントロダクション
• 外来手術センター
• 在宅医療環境
• 病院とクリニック

第9章 血管アクセスデバイス市場：用途別

• イントロダクション
• 輸血
• 診断と検査
• 薬剤投与
  • 抗生物質の点滴
  • 化学療法

第10章 南北アメリカの血管アクセスデバイス市場

• イントロダクション
• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第11章 アジア太平洋の血管アクセスデバイス市場

• イントロダクション
• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第12章 欧州・中東・アフリカの血管アクセスデバイス市場

• イントロダクション
• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第13章 競合情勢

• 市場シェア分析、2024年
• FPNVポジショニングマトリックス、2024年
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• 3M Company
• Access Vascular, Inc.
• AMECATH
• AngioDynamics, Inc.
• Argon Medical Devices, Inc.
• Asahi Kasei Medical Co., Ltd.
• B. Braun Melsungen AG
• Baxter International Inc.
• Becton, Dickinson and Company
• Cook Medical, Inc.
• Edwards Lifesciences Corporation
• Fresenius Medical Care AG & Co. KGaA
• Fujifilm Sonosite, Inc.
• ICU Medical, Inc.
• Kimal PLC
• Medical Components, Inc.
• Medtronic PLC
• Nipro Medical Corporation
• Prodimed
• Semler Technologies Inc.
• Siemens Healthcare AG
• Smiths Medical, Inc.
• Teleflex Incorporated
• Terumo Corporation
• Versago Vascular Access
• Vygon SA
• W. L. Gore & Associates, Inc

LIST OF FIGURES

• FIGURE 1. VASCULAR ACCESS DEVICE MARKET MULTI-CURRENCY
• FIGURE 2. VASCULAR ACCESS DEVICE MARKET MULTI-LANGUAGE
• FIGURE 3. VASCULAR ACCESS DEVICE MARKET RESEARCH PROCESS
• FIGURE 4. VASCULAR ACCESS DEVICE MARKET SIZE, 2024 VS 2030
• FIGURE 5. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 6. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 7. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY TYPE, 2024 VS 2030 (%)
• FIGURE 9. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY AGE GROUP, 2024 VS 2030 (%)
• FIGURE 11. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY AGE GROUP, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY END USER, 2024 VS 2030 (%)
• FIGURE 13. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 14. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
• FIGURE 15. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 16. AMERICAS VASCULAR ACCESS DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
• FIGURE 17. AMERICAS VASCULAR ACCESS DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 18. UNITED STATES VASCULAR ACCESS DEVICE MARKET SIZE, BY STATE, 2024 VS 2030 (%)
• FIGURE 19. UNITED STATES VASCULAR ACCESS DEVICE MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 20. ASIA-PACIFIC VASCULAR ACCESS DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
• FIGURE 21. ASIA-PACIFIC VASCULAR ACCESS DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 22. EUROPE, MIDDLE EAST & AFRICA VASCULAR ACCESS DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
• FIGURE 23. EUROPE, MIDDLE EAST & AFRICA VASCULAR ACCESS DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 24. VASCULAR ACCESS DEVICE MARKET SHARE, BY KEY PLAYER, 2024
• FIGURE 25. VASCULAR ACCESS DEVICE MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

• TABLE 1. VASCULAR ACCESS DEVICE MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
• TABLE 3. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. VASCULAR ACCESS DEVICE MARKET DYNAMICS
• TABLE 7. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY CENTRAL VENOUS CATHETERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY PERIPHERAL VASCULAR ACCESS DEVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY LONG PERIPHERAL INTRAVENOUS CATHETER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY SHORT PERIPHERAL INTRAVENOUS CATHETER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY PERIPHERAL VASCULAR ACCESS DEVICES, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY ADULT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY GERIATRIC, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY HOME HEALTHCARE SETTINGS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY BLOOD TRANSFUSION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY DIAGNOSTICS & TESTING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY DRUG ADMINISTRATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY ANTIBIOTIC INFUSION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY CHEMOTHERAPY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY DRUG ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 28. AMERICAS VASCULAR ACCESS DEVICE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 29. AMERICAS VASCULAR ACCESS DEVICE MARKET SIZE, BY PERIPHERAL VASCULAR ACCESS DEVICES, 2018-2030 (USD MILLION)
• TABLE 30. AMERICAS VASCULAR ACCESS DEVICE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 31. AMERICAS VASCULAR ACCESS DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 32. AMERICAS VASCULAR ACCESS DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 33. AMERICAS VASCULAR ACCESS DEVICE MARKET SIZE, BY DRUG ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 34. AMERICAS VASCULAR ACCESS DEVICE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 35. ARGENTINA VASCULAR ACCESS DEVICE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 36. ARGENTINA VASCULAR ACCESS DEVICE MARKET SIZE, BY PERIPHERAL VASCULAR ACCESS DEVICES, 2018-2030 (USD MILLION)
• TABLE 37. ARGENTINA VASCULAR ACCESS DEVICE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 38. ARGENTINA VASCULAR ACCESS DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 39. ARGENTINA VASCULAR ACCESS DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 40. ARGENTINA VASCULAR ACCESS DEVICE MARKET SIZE, BY DRUG ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 41. BRAZIL VASCULAR ACCESS DEVICE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 42. BRAZIL VASCULAR ACCESS DEVICE MARKET SIZE, BY PERIPHERAL VASCULAR ACCESS DEVICES, 2018-2030 (USD MILLION)
• TABLE 43. BRAZIL VASCULAR ACCESS DEVICE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 44. BRAZIL VASCULAR ACCESS DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 45. BRAZIL VASCULAR ACCESS DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 46. BRAZIL VASCULAR ACCESS DEVICE MARKET SIZE, BY DRUG ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 47. CANADA VASCULAR ACCESS DEVICE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 48. CANADA VASCULAR ACCESS DEVICE MARKET SIZE, BY PERIPHERAL VASCULAR ACCESS DEVICES, 2018-2030 (USD MILLION)
• TABLE 49. CANADA VASCULAR ACCESS DEVICE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 50. CANADA VASCULAR ACCESS DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 51. CANADA VASCULAR ACCESS DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 52. CANADA VASCULAR ACCESS DEVICE MARKET SIZE, BY DRUG ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 53. MEXICO VASCULAR ACCESS DEVICE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 54. MEXICO VASCULAR ACCESS DEVICE MARKET SIZE, BY PERIPHERAL VASCULAR ACCESS DEVICES, 2018-2030 (USD MILLION)
• TABLE 55. MEXICO VASCULAR ACCESS DEVICE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 56. MEXICO VASCULAR ACCESS DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 57. MEXICO VASCULAR ACCESS DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 58. MEXICO VASCULAR ACCESS DEVICE MARKET SIZE, BY DRUG ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 59. UNITED STATES VASCULAR ACCESS DEVICE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 60. UNITED STATES VASCULAR ACCESS DEVICE MARKET SIZE, BY PERIPHERAL VASCULAR ACCESS DEVICES, 2018-2030 (USD MILLION)
• TABLE 61. UNITED STATES VASCULAR ACCESS DEVICE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 62. UNITED STATES VASCULAR ACCESS DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 63. UNITED STATES VASCULAR ACCESS DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 64. UNITED STATES VASCULAR ACCESS DEVICE MARKET SIZE, BY DRUG ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 65. UNITED STATES VASCULAR ACCESS DEVICE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 66. ASIA-PACIFIC VASCULAR ACCESS DEVICE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 67. ASIA-PACIFIC VASCULAR ACCESS DEVICE MARKET SIZE, BY PERIPHERAL VASCULAR ACCESS DEVICES, 2018-2030 (USD MILLION)
• TABLE 68. ASIA-PACIFIC VASCULAR ACCESS DEVICE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 69. ASIA-PACIFIC VASCULAR ACCESS DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 70. ASIA-PACIFIC VASCULAR ACCESS DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 71. ASIA-PACIFIC VASCULAR ACCESS DEVICE MARKET SIZE, BY DRUG ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 72. ASIA-PACIFIC VASCULAR ACCESS DEVICE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 73. AUSTRALIA VASCULAR ACCESS DEVICE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 74. AUSTRALIA VASCULAR ACCESS DEVICE MARKET SIZE, BY PERIPHERAL VASCULAR ACCESS DEVICES, 2018-2030 (USD MILLION)
• TABLE 75. AUSTRALIA VASCULAR ACCESS DEVICE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 76. AUSTRALIA VASCULAR ACCESS DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 77. AUSTRALIA VASCULAR ACCESS DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 78. AUSTRALIA VASCULAR ACCESS DEVICE MARKET SIZE, BY DRUG ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 79. CHINA VASCULAR ACCESS DEVICE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 80. CHINA VASCULAR ACCESS DEVICE MARKET SIZE, BY PERIPHERAL VASCULAR ACCESS DEVICES, 2018-2030 (USD MILLION)
• TABLE 81. CHINA VASCULAR ACCESS DEVICE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 82. CHINA VASCULAR ACCESS DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 83. CHINA VASCULAR ACCESS DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 84. CHINA VASCULAR ACCESS DEVICE MARKET SIZE, BY DRUG ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 85. INDIA VASCULAR ACCESS DEVICE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 86. INDIA VASCULAR ACCESS DEVICE MARKET SIZE, BY PERIPHERAL VASCULAR ACCESS DEVICES, 2018-2030 (USD MILLION)
• TABLE 87. INDIA VASCULAR ACCESS DEVICE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 88. INDIA VASCULAR ACCESS DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 89. INDIA VASCULAR ACCESS DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 90. INDIA VASCULAR ACCESS DEVICE MARKET SIZE, BY DRUG ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 91. INDONESIA VASCULAR ACCESS DEVICE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 92. INDONESIA VASCULAR ACCESS DEVICE MARKET SIZE, BY PERIPHERAL VASCULAR ACCESS DEVICES, 2018-2030 (USD MILLION)
• TABLE 93. INDONESIA VASCULAR ACCESS DEVICE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 94. INDONESIA VASCULAR ACCESS DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 95. INDONESIA VASCULAR ACCESS DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 96. INDONESIA VASCULAR ACCESS DEVICE MARKET SIZE, BY DRUG ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 97. JAPAN VASCULAR ACCESS DEVICE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 98. JAPAN VASCULAR ACCESS DEVICE MARKET SIZE, BY PERIPHERAL VASCULAR ACCESS DEVICES, 2018-2030 (USD MILLION)
• TABLE 99. JAPAN VASCULAR ACCESS DEVICE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 100. JAPAN VASCULAR ACCESS DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 101. JAPAN VASCULAR ACCESS DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 102. JAPAN VASCULAR ACCESS DEVICE MARKET SIZE, BY DRUG ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 103. MALAYSIA VASCULAR ACCESS DEVICE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 104. MALAYSIA VASCULAR ACCESS DEVICE MARKET SIZE, BY PERIPHERAL VASCULAR ACCESS DEVICES, 2018-2030 (USD MILLION)
• TABLE 105. MALAYSIA VASCULAR ACCESS DEVICE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 106. MALAYSIA VASCULAR ACCESS DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 107. MALAYSIA VASCULAR ACCESS DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 108. MALAYSIA VASCULAR ACCESS DEVICE MARKET SIZE, BY DRUG ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 109. PHILIPPINES VASCULAR ACCESS DEVICE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 110. PHILIPPINES VASCULAR ACCESS DEVICE MARKET SIZE, BY PERIPHERAL VASCULAR ACCESS DEVICES, 2018-2030 (USD MILLION)
• TABLE 111. PHILIPPINES VASCULAR ACCESS DEVICE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 112. PHILIPPINES VASCULAR ACCESS DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 113. PHILIPPINES VASCULAR ACCESS DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 114. PHILIPPINES VASCULAR ACCESS DEVICE MARKET SIZE, BY DRUG ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 115. SINGAPORE VASCULAR ACCESS DEVICE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 116. SINGAPORE VASCULAR ACCESS DEVICE MARKET SIZE, BY PERIPHERAL VASCULAR ACCESS DEVICES, 2018-2030 (USD MILLION)
• TABLE 117. SINGAPORE VASCULAR ACCESS DEVICE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 118. SINGAPORE VASCULAR ACCESS DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 119. SINGAPORE VASCULAR ACCESS DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 120. SINGAPORE VASCULAR ACCESS DEVICE MARKET SIZE, BY DRUG ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 121. SOUTH KOREA VASCULAR ACCESS DEVICE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 122. SOUTH KOREA VASCULAR ACCESS DEVICE MARKET SIZE, BY PERIPHERAL VASCULAR ACCESS DEVICES, 2018-2030 (USD MILLION)
• TABLE 123. SOUTH KOREA VASCULAR ACCESS DEVICE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 124. SOUTH KOREA VASCULAR ACCESS DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 125. SOUTH KOREA VASCULAR ACCESS DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 126. SOUTH KOREA VASCULAR ACCESS DEVICE MARKET SIZE, BY DRUG ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 127. TAIWAN VASCULAR ACCESS DEVICE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 128. TAIWAN VASCULAR ACCESS DEVICE MARKET SIZE, BY PERIPHERAL VASCULAR ACCESS DEVICES, 2018-2030 (USD MILLION)
• TABLE 129. TAIWAN VASCULAR ACCESS DEVICE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 130. TAIWAN VASCULAR ACCESS DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 131. TAIWAN VASCULAR ACCESS DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 132. TAIWAN VASCULAR ACCESS DEVICE MARKET SIZE, BY DRUG ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 133. THAILAND VASCULAR ACCESS DEVICE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 134. THAILAND VASCULAR ACCESS DEVICE MARKET SIZE, BY PERIPHERAL VASCULAR ACCESS DEVICES, 2018-2030 (USD MILLION)
• TABLE 135. THAILAND VASCULAR ACCESS DEVICE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 136. THAILAND VASCULAR ACCESS DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 137. THAILAND VASCULAR ACCESS DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 138. THAILAND VASCULAR ACCESS DEVICE MARKET SIZE, BY DRUG ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 139. VIETNAM VASCULAR ACCESS DEVICE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 140. VIETNAM VASCULAR ACCESS DEVICE MARKET SIZE, BY PERIPHERAL VASCULAR ACCESS DEVICES, 2018-2030 (USD MILLION)
• TABLE 141. VIETNAM VASCULAR ACCESS DEVICE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 142. VIETNAM VASCULAR ACCESS DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 143. VIETNAM VASCULAR ACCESS DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 144. VIETNAM VASCULAR ACCESS DEVICE MARKET SIZE, BY DRUG ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 145. EUROPE, MIDDLE EAST & AFRICA VASCULAR ACCESS DEVICE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 146. EUROPE, MIDDLE EAST & AFRICA VASCULAR ACCESS DEVICE MARKET SIZE, BY PERIPHERAL VASCULAR ACCESS DEVICES, 2018-2030 (USD MILLION)
• TABLE 147. EUROPE, MIDDLE EAST & AFRICA VASCULAR ACCESS DEVICE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 148. EUROPE, MIDDLE EAST & AFRICA VASCULAR ACCESS DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 149. EUROPE, MIDDLE EAST & AFRICA VASCULAR ACCESS DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 150. EUROPE, MIDDLE EAST & AFRICA VASCULAR ACCESS DEVICE MARKET SIZE, BY DRUG ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 151. EUROPE, MIDDLE EAST & AFRICA VASCULAR ACCESS DEVICE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 152. DENMARK VASCULAR ACCESS DEVICE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 153. DENMARK VASCULAR ACCESS DEVICE MARKET SIZE, BY PERIPHERAL VASCULAR ACCESS DEVICES, 2018-2030 (USD MILLION)
• TABLE 154. DENMARK VASCULAR ACCESS DEVICE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 155. DENMARK VASCULAR ACCESS DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 156. DENMARK VASCULAR ACCESS DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 157. DENMARK VASCULAR ACCESS DEVICE MARKET SIZE, BY DRUG ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 158. EGYPT VASCULAR ACCESS DEVICE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 159. EGYPT VASCULAR ACCESS DEVICE MARKET SIZE, BY PERIPHERAL VASCULAR ACCESS DEVICES, 2018-2030 (USD MILLION)
• TABLE 160. EGYPT VASCULAR ACCESS DEVICE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 161. EGYPT VASCULAR ACCESS DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 162. EGYPT VASCULAR ACCESS DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 163. EGYPT VASCULAR ACCESS DEVICE MARKET SIZE, BY DRUG ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 164. FINLAND VASCULAR ACCESS DEVICE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 165. FINLAND VASCULAR ACCESS DEVICE MARKET SIZE, BY PERIPHERAL VASCULAR ACCESS DEVICES, 2018-2030 (USD MILLION)
• TABLE 166. FINLAND VASCULAR ACCESS DEVICE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 167. FINLAND VASCULAR ACCESS DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 168. FINLAND VASCULAR ACCESS DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 169. FINLAND VASCULAR ACCESS DEVICE MARKET SIZE, BY DRUG ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 170. FRANCE VASCULAR ACCESS DEVICE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 171. FRANCE VASCULAR ACCESS DEVICE MARKET SIZE, BY PERIPHERAL VASCULAR ACCESS DEVICES, 2018-2030 (USD MILLION)
• TABLE 172. FRANCE VASCULAR ACCESS DEVICE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 173. FRANCE VASCULAR ACCESS DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 174. FRANCE VASCULAR ACCESS DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 175. FRANCE VASCULAR ACCESS DEVICE MARKET SIZE, BY DRUG ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 176. GERMANY VASCULAR ACCESS DEVICE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 177. GERMANY VASCULAR ACCESS DEVICE MARKET SIZE, BY PERIPHERAL VASCULAR ACCESS DEVICES, 2018-2030 (USD MILLION)
• TABLE 178. GERMANY VASCULAR ACCESS DEVICE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 179. GERMANY VASCULAR ACCESS DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 180. GERMANY VASCULAR ACCESS DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 181. GERMANY VASCULAR ACCESS DEVICE MARKET SIZE, BY DRUG ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 182. ISRAEL VASCULAR ACCESS DEVICE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 183. ISRAEL VASCULAR ACCESS DEVICE MARKET SIZE, BY PERIPHERAL VASCULAR ACCESS DEVICES, 2018-2030 (USD MILLION)
• TABLE 184. ISRAEL VASCULAR ACCESS DEVICE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 185. ISRAEL VASCULAR ACCESS DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 186. ISRAEL VASCULAR ACCESS DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 187. ISRAEL VASCULAR ACCESS DEVICE MARKET SIZE, BY DRUG ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 188. ITALY VASCULAR ACCESS DEVICE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 189. ITALY VASCULAR ACCESS DEVICE MARKET SIZE, BY PERIPHERAL VASCULAR ACCESS DEVICES, 2018-2030 (USD MILLION)
• TABLE 190. ITALY VASCULAR ACCESS DEVICE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 191. ITALY VASCULAR ACCESS DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 192. ITALY VASCULAR ACCESS DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 193. ITALY VASCULAR ACCESS DEVICE MARKET SIZE, BY DRUG ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 194. NETHERLANDS VASCULAR ACCESS DEVICE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 195. NETHERLANDS VASCULAR ACCESS DEVICE MARKET SIZE, BY PERIPHERAL VASCULAR ACCESS DEVICES, 2018-2030 (USD MILLION)
• TABLE 196. NETHERLANDS VASCULAR ACCESS DEVICE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 197. NETHERLANDS VASCULAR ACCESS DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 198. NETHERLANDS VASCULAR ACCESS DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 199. NETHERLANDS VASCULAR ACCESS DEVICE MARKET SIZE, BY DRUG ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 200. NIGERIA VASCULAR ACCESS DEVICE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 201. NIGERIA VASCULAR ACCESS DEVICE MARKET SIZE, BY PERIPHERAL VASCULAR ACCESS DEVICES, 2018-2030 (USD MILLION)
• TABLE 202. NIGERIA VASCULAR ACCESS DEVICE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 203. NIGERIA VASCULAR ACCESS DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 204. NIGERIA VASCULAR ACCESS DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 205. NIGERIA VASCULAR ACCESS DEVICE MARKET SIZE, BY DRUG ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 206. NORWAY VASCULAR ACCESS DEVICE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 207. NORWAY VASCULAR ACCESS DEVICE MARKET SIZE, BY PERIPHERAL VASCULAR ACCESS DEVICES, 2018-2030 (USD MILLION)
• TABLE 208. NORWAY VASCULAR ACCESS DEVICE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 209. NORWAY VASCULAR ACCESS DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 210. NORWAY VASCULAR ACCESS DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 211. NORWAY VASCULAR ACCESS DEVICE MARKET SIZE, BY DRUG ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 212. POLAND VASCULAR ACCESS DEVICE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 213. POLAND VASCULAR ACCESS DEVICE MARKET SIZE, BY PERIPHERAL VASCULAR ACCESS DEVICES, 2018-2030 (USD MILLION)
• TABLE 214. POLAND VASCULAR ACCESS DEVICE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 215. POLAND VASCULAR ACCESS DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 216. POLAND VASCULAR ACCESS DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 217. POLAND VASCULAR ACCESS DEVICE MARKET SIZE, BY DRUG ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 218. QATAR VASCULAR ACCESS DEVICE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 219. QATAR VASCULAR ACCESS DEVICE MARKET SIZE, BY PERIPHERAL VASCULAR ACCESS DEVICES, 2018-2030 (USD MILLION)
• TABLE 220. QATAR VASCULAR ACCESS DEVICE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 221. QATAR VASCULAR ACCESS DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 222. QATAR VASCULAR ACCESS DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 223. QATAR VASCULAR ACCESS DEVICE MARKET SIZE, BY DRUG ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 224. RUSSIA VASCULAR ACCESS DEVICE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 225. RUSSIA VASCULAR ACCESS DEVICE MARKET SIZE, BY PERIPHERAL VASCULAR ACCESS DEVICES, 2018-2030 (USD MILLION)
• TABLE 226. RUSSIA VASCULAR ACCESS DEVICE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 227. RUSSIA VASCULAR ACCESS DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 228. RUSSIA VASCULAR ACCESS DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 229. RUSSIA VASCULAR ACCESS DEVICE MARKET SIZE, BY DRUG ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 230. SAUDI ARABIA VASCULAR ACCESS DEVICE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 231. SAUDI ARABIA VASCULAR ACCESS DEVICE MARKET SIZE, BY PERIPHERAL VASCULAR ACCESS DEVICES, 2018-2030 (USD MILLION)
• TABLE 232. SAUDI ARABIA VASCULAR ACCESS DEVICE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 233. SAUDI ARABIA VASCULAR ACCESS DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 234. SAUDI ARABIA VASCULAR ACCESS DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 235. SAUDI ARABIA VASCULAR ACCESS DEVICE MARKET SIZE, BY DRUG ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 236. SOUTH AFRICA VASCULAR ACCESS DEVICE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 237. SOUTH AFRICA VASCULAR ACCESS DEVICE MARKET SIZE, BY PERIPHERAL VASCULAR ACCESS DEVICES, 2018-2030 (USD MILLION)
• TABLE 238. SOUTH AFRICA VASCULAR ACCESS DEVICE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 239. SOUTH AFRICA VASCULAR ACCESS DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 240. SOUTH AFRICA VASCULAR ACCESS DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 241. SOUTH AFRICA VASCULAR ACCESS DEVICE MARKET SIZE, BY DRUG ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 242. SPAIN VASCULAR ACCESS DEVICE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 243. SPAIN VASCULAR ACCESS DEVICE MARKET SIZE, BY PERIPHERAL VASCULAR ACCESS DEVICES, 2018-2030 (USD MILLION)
• TABLE 244. SPAIN VASCULAR ACCESS DEVICE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 245. SPAIN VASCULAR ACCESS DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 246. SPAIN VASCULAR ACCESS DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 247. SPAIN VASCULAR ACCESS DEVICE MARKET SIZE, BY DRUG ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 248. SWEDEN VASCULAR ACCESS DEVICE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 249. SWEDEN VASCULAR ACCESS DEVICE MARKET SIZE, BY PERIPHERAL VASCULAR ACCESS DEVICES, 2018-2030 (USD MILLION)
• TABLE 250. SWEDEN VASCULAR ACCESS DEVICE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 251. SWEDEN VASCULAR ACCESS DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 252. SWEDEN VASCULAR ACCESS DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 253. SWEDEN VASCULAR ACCESS DEVICE MARKET SIZE, BY DRUG ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 254. SWITZERLAND VASCULAR ACCESS DEVICE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 255. SWITZERLAND VASCULAR ACCESS DEVICE MARKET SIZE, BY PERIPHERAL VASCULAR ACCESS DEVICES, 2018-2030 (USD MILLION)
• TABLE 256. SWITZERLAND VASCULAR ACCESS DEVICE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 257. SWITZERLAND VASCULAR ACCESS DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 258. SWITZERLAND VASCULAR ACCESS DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 259. SWITZERLAND VASCULAR ACCESS DEVICE MARKET SIZE, BY DRUG ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 260. TURKEY VASCULAR ACCESS DEVICE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 261. TURKEY VASCULAR ACCESS DEVICE MARKET SIZE, BY PERIPHERAL VASCULAR ACCESS DEVICES, 2018-2030 (USD MILLION)
• TABLE 262. TURKEY VASCULAR ACCESS DEVICE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 263. TURKEY VASCULAR ACCESS DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 264. TURKEY VASCULAR ACCESS DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 265. TURKEY VASCULAR ACCESS DEVICE MARKET SIZE, BY DRUG ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 266. UNITED ARAB EMIRATES VASCULAR ACCESS DEVICE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 267. UNITED ARAB EMIRATES VASCULAR ACCESS DEVICE MARKET SIZE, BY PERIPHERAL VASCULAR ACCESS DEVICES, 2018-2030 (USD MILLION)
• TABLE 268. UNITED ARAB EMIRATES VASCULAR ACCESS DEVICE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 269. UNITED ARAB EMIRATES VASCULAR ACCESS DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 270. UNITED ARAB EMIRATES VASCULAR ACCESS DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 271. UNITED ARAB EMIRATES VASCULAR ACCESS DEVICE MARKET SIZE, BY DRUG ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 272. UNITED KINGDOM VASCULAR ACCESS DEVICE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 273. UNITED KINGDOM VASCULAR ACCESS DEVICE MARKET SIZE, BY PERIPHERAL VASCULAR ACCESS DEVICES, 2018-2030 (USD MILLION)
• TABLE 274. UNITED KINGDOM VASCULAR ACCESS DEVICE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 275. UNITED KINGDOM VASCULAR ACCESS DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 276. UNITED KINGDOM VASCULAR ACCESS DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 277. UNITED KINGDOM VASCULAR ACCESS DEVICE MARKET SIZE, BY DRUG ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 278. VASCULAR ACCESS DEVICE MARKET SHARE, BY KEY PLAYER, 2024
• TABLE 279. VASCULAR ACCESS DEVICE MARKET, FPNV POSITIONING MATRIX, 2024

The Vascular Access Device Market was valued at USD 5.11 billion in 2024 and is projected to grow to USD 5.48 billion in 2025, with a CAGR of 7.71%, reaching USD 7.98 billion by 2030.

In today's dynamic healthcare environment, the vascular access device market is increasingly recognized as a critical component in the delivery of efficient care. The expanding use of vascular access devices such as central venous catheters and peripheral vascular access devices underlines the need for robust, reliable, and adaptable medical solutions. These devices are pivotal in a variety of treatments and diagnostic applications, ensuring that patients receive therapies effectively and safely in settings ranging from hospitals to home healthcare.

Healthcare organizations continually seek innovations that not only offer improved patient outcomes but also streamline clinical processes. As procedures have evolved, so has the technical sophistication of these devices. The integration of new materials, advanced catheter designs, and enhanced biocompatibility has helped manufacturers meet the dual demand for safety and performance. Market leaders have demonstrated a strong commitment to research and development, reflecting the broader industry trend towards value-based care.

The market's evolution is further shaped by a global shift towards minimally invasive treatments and a higher preference for outpatient care. This transformation is supported by developments in wearable technologies and remote monitoring, adding another layer of resilience and adaptability to patient management frameworks. Overall, the current landscape is marked by innovation, strategic collaborations, and a relentless drive towards excellence in patient care.

Transformative Shifts Redefining the Vascular Access Device Landscape

Recent years have witnessed transformative shifts in the vascular access device market, driven by rapid technological advancements and an evolving patient care paradigm. New product innovations have brought revolutionary design improvements that emphasize both functionality and patient safety. As performance metrics advance alongside cost efficiencies, producers are transitioning from traditional models to designs that incorporate integrated monitoring and real-time data analytics.

Healthcare providers are increasingly adopting devices that enhance procedural accuracy, reduce complication rates, and contribute to better patient outcomes. These shifts are not merely limited to product attributes; they are reflective of broader systemic transformations, including streamlined supply chains, digital integration in hospital systems, and an emphasis on personalized care. As the market has expanded, the adoption of evidence-based practices has facilitated a faster pace of innovation. Additionally, emerging trends in regulatory practices have encouraged a culture of continuous quality improvement within the industry, promoting enhanced standardization and safety protocols.

Manufacturers and stakeholders are now leveraging advancements in material science, fluid dynamics, and real-time monitoring to ensure that every device performs optimally in diverse clinical scenarios. This evolution has resulted in a market that is not only competitive on the basis of technology but also resilient in the face of ever-changing patient demographics and healthcare delivery models.

Insights Through Detailed Market Segmentation

The market segmentation insights reveal intricate aspects that underpin the dynamics of the vascular access device industry. Analysis based on type shows a thorough study across central venous catheters and peripheral vascular access devices, with further scrutiny into long peripheral intravenous catheters and short peripheral intravenous catheters. This nuanced categorization helps identify trends in device usage patterns and technological advancements specific to each type. The segmentation based on age groups targets adult, geriatric, and pediatric populations, providing a comprehensive look at patient-specific needs and challenges across life spans.

Furthermore, segmentation by end user emphasizes settings such as ambulatory surgical centers, home healthcare environments, and hospitals and clinics, which underscores the varied clinical requirements and procedural standards inherent in these settings. The analytical framework is extended to applications that include blood transfusion, diagnostics and testing, and drug administration. In drug administration, the focus on antibiotic infusion and chemotherapy facilitates a better understanding of market demand in specialized treatment protocols. This integrative segmentation approach enables stakeholders to tailor strategies that precisely align with the needs of diverse segments, ensuring that products and services meet the expectations of a broad and increasingly complex customer base.

Based on Type, market is studied across Central Venous Catheters and Peripheral Vascular Access Devices. The Peripheral Vascular Access Devices is further studied across Long Peripheral Intravenous Catheter and Short Peripheral Intravenous Catheter.

Based on Age Group, market is studied across Adult, Geriatric, and Pediatric.

Based on End User, market is studied across Ambulatory Surgical Centers, Home Healthcare Settings, and Hospitals & Clinics.

Based on Application, market is studied across Blood Transfusion, Diagnostics & Testing, and Drug Administration. The Drug Administration is further studied across Antibiotic Infusion and Chemotherapy.

Regional Trends and Their Impact on Market Dynamics

A regional perspective provides valuable insight into the growing demand and unique opportunities within the vascular access device market. Detailed exploration of major regions such as the Americas, Europe, Middle East & Africa, and Asia-Pacific highlights the differing market maturity levels and regulatory frameworks that influence device adoption. The Americas continue to lead in terms of advanced healthcare infrastructure and high rates of technology integration. In contrast, Europe, Middle East & Africa is witnessing rapid modernization of healthcare systems with a pronounced emphasis on safety and efficiency standards. Meanwhile, the Asia-Pacific region, characterized by emerging economies and a growing middle class, is experiencing significant growth driven by increased investments in healthcare facilities and technology.

These regional insights help clarify how demographic shifts, economic development, and local healthcare policies shape the competitive landscape and fuel demand for innovative vascular access solutions. Understanding these dynamics is critical for stakeholders aiming to optimize market penetration strategies, whether by addressing regulatory challenges or capitalizing on regions with high growth potential.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Key Insights from Industry Leaders and Major Market Players

A closer examination of the competitive environment reveals that a host of influential companies are shaping the vascular access device market. Industry giants such as 3M Company, Access Vascular, Inc., AMECATH, AngioDynamics, Inc., and Argon Medical Devices, Inc. have established significant footholds in the market through continuous innovation and strategic positioning. These companies, along with notable players including Asahi Kasei Medical Co., Ltd., B. Braun Melsungen AG, Baxter International Inc., and Becton, Dickinson and Company, play pivotal roles in driving advancements in technology and patient care standards.

Leading organizations such as Cook Medical, Inc., Edwards Lifesciences Corporation, Fresenius Medical Care AG & Co. KGaA, Fujifilm Sonosite, Inc., and ICU Medical, Inc. have excelled in developing products that address both clinical efficacy and ease of use. The landscape is further enriched by the contributions of Kimal PLC, Medical Components, Inc., Medtronic PLC, Nipro Medical Corporation, and Prodimed, whose expertise helps set rigorous quality benchmarks. Additional market influencers like Semler Technologies Inc., Siemens Healthcare AG, Smiths Medical, Inc., Teleflex Incorporated, Terumo Corporation, Versago Vascular Access, Vygon SA, and W. L. Gore & Associates, Inc. strengthen the market's competitive edge. Analyzing the strategic moves and innovations of these companies provides a comprehensive understanding of market trends, competitive intensity, and future growth prospects.

The report delves into recent significant developments in the Vascular Access Device Market, highlighting leading vendors and their innovative profiles. These include 3M Company, Access Vascular, Inc., AMECATH, AngioDynamics, Inc., Argon Medical Devices, Inc., Asahi Kasei Medical Co., Ltd., B. Braun Melsungen AG, Baxter International Inc., Becton, Dickinson and Company, Cook Medical, Inc., Edwards Lifesciences Corporation, Fresenius Medical Care AG & Co. KGaA, Fujifilm Sonosite, Inc., ICU Medical, Inc., Kimal PLC, Medical Components, Inc., Medtronic PLC, Nipro Medical Corporation, Prodimed, Semler Technologies Inc., Siemens Healthcare AG, Smiths Medical, Inc., Teleflex Incorporated, Terumo Corporation, Versago Vascular Access, Vygon SA, and W. L. Gore & Associates, Inc. Strategic Recommendations for Market Leaders

For industry leaders charting the future, a combination of innovation, collaboration, and adaptation is paramount. Leaders are encouraged to invest in advanced research and development efforts to foster the creation of next-generation vascular access devices that combine efficiency with enhanced patient safety profiles. By integrating emerging technologies such as digital health monitoring and real-time analytics into product portfolios, companies can stay ahead of the demand curve and meet evolving clinical requirements.

Additionally, focusing on expanding geographic reach while localizing product offerings to address regional nuances can vastly improve market penetration. Companies should also consider forming strategic partnerships with regional healthcare providers and technology firms to facilitate smoother product rollouts and service adoption. Embracing collaborative ecosystems enables the leveraging of shared expertise, a critical factor in accelerating product innovation and addressing global regulatory challenges.

Finally, maintaining agility in response to shifting market demographics and treatment paradigms is essential. Industry leaders must continuously reassess their strategies to ensure alignment with the rapid pace of technological advancement and the evolving demands of diverse healthcare settings.

Conclusion: The Road Ahead for Vascular Access Devices

In summary, the vascular access device market is in a state of significant evolution, marked by rapid technological progress and a shifting landscape driven by global demographics and healthcare imperatives. The integration of robust segmentation insights and regional trends highlights the multifaceted nature of market demand, while the competitive actions of established industry players underscore the importance of innovation and strategic foresight. As new standards in patient care continue to emerge, stakeholders are presented with abundant opportunities to refine their approaches and drive value across clinical settings.

The future trajectory of this market hinges on the collective ability to meet sophisticated patient needs, streamline clinical operations, and adopt agile strategies that respond to an ever-changing healthcare environment. A proactive stance today will pave the way for greater advancements in safety, precision, and overall patient outcomes tomorrow.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising cases of chronic illnesses create sustained need for long-term vascular access solutions
    • 5.1.1.2. Increasing number of surgical procedures requiring vascular access devices for fluid administration
  • 5.1.2. Restraints
    • 5.1.2.1. High costs and reimbursement issues along with significant product recalls
  • 5.1.3. Opportunities
    • 5.1.3.1. Developing innovative antimicrobial coating technologies to reduce device-related infections
    • 5.1.3.2. Expanding home healthcare sector is increasing the need for portable and user-friendly vascular devices
  • 5.1.4. Challenges
    • 5.1.4.1. Risk of complications and infections associated with VADs along with regulatory hurdles
• 5.2. Market Segmentation Analysis
  • 5.2.1. Type: Burgeoning adoption of peripheral vascular access devices for short-term therapy
  • 5.2.2. End User: Expanding utilization of vascular-access-devices by hospitals and clinics owing to their high volume of inpatient and outpatient procedures
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Vascular Access Device Market, by Type

• 6.1. Introduction
• 6.2. Central Venous Catheters
• 6.3. Peripheral Vascular Access Devices
  • 6.3.1. Long Peripheral Intravenous Catheter
  • 6.3.2. Short Peripheral Intravenous Catheter

7. Vascular Access Device Market, by Age Group

• 7.1. Introduction
• 7.2. Adult
• 7.3. Geriatric
• 7.4. Pediatric

8. Vascular Access Device Market, by End User

• 8.1. Introduction
• 8.2. Ambulatory Surgical Centers
• 8.3. Home Healthcare Settings
• 8.4. Hospitals & Clinics

9. Vascular Access Device Market, by Application

• 9.1. Introduction
• 9.2. Blood Transfusion
• 9.3. Diagnostics & Testing
• 9.4. Drug Administration
  • 9.4.1. Antibiotic Infusion
  • 9.4.2. Chemotherapy

10. Americas Vascular Access Device Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Vascular Access Device Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Vascular Access Device Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2024
• 13.2. FPNV Positioning Matrix, 2024
• 13.3. Competitive Scenario Analysis
  • 13.3.1. BD develops enhanced system for immediate IV access in emergencies
  • 13.3.2. Teleflex transform vascular access with new Arrow VPS Rhythm DLX and NaviCurve in Canada
  • 13.3.3. Access Vascular partners with Capstone for expansion
• 13.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. 3M Company
• 2. Access Vascular, Inc.
• 3. AMECATH
• 4. AngioDynamics, Inc.
• 5. Argon Medical Devices, Inc.
• 6. Asahi Kasei Medical Co., Ltd.
• 7. B. Braun Melsungen AG
• 8. Baxter International Inc.
• 9. Becton, Dickinson and Company
• 10. Cook Medical, Inc.
• 11. Edwards Lifesciences Corporation
• 12. Fresenius Medical Care AG & Co. KGaA
• 13. Fujifilm Sonosite, Inc.
• 14. ICU Medical, Inc.
• 15. Kimal PLC
• 16. Medical Components, Inc.
• 17. Medtronic PLC
• 18. Nipro Medical Corporation
• 19. Prodimed
• 20. Semler Technologies Inc.
• 21. Siemens Healthcare AG
• 22. Smiths Medical, Inc.
• 23. Teleflex Incorporated
• 24. Terumo Corporation
• 25. Versago Vascular Access
• 26. Vygon SA
• 27. W. L. Gore & Associates, Inc